⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28072326 | 0.91 | — | — | |
| SCHEMBL1685841 | 0.88 | FDPS (0.48) | — | |
| SCHEMBL4633334 | 0.88 | FDPS (0.48) | — | |
| SCHEMBL8945630 | 0.88 | FDPS (0.48) | — | |
| SCHEMBL51788 | 0.81 | — | — | |
| SCHEMBL3794316 | 0.80 | — | — | |
| SCHEMBL11442316 | 0.79 | — | — | |
| SCHEMBL27592824 | 0.77 | — | — | |
| SCHEMBL27645665 | 0.77 | — | — | |
| SCHEMBL4923394 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102014901-A | Pharmaceutical composition | TAKEDA PHARMACEUTICAL | 2011-04-13 | — | — | CN | disclosed |
| US-20100331357-A1 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2252291-A1 | PHARMACEUTICAL COMPOSITION | Takeda Pharmaceutical Company Limited (JP) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009107877-A1 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-09-03 | — | — | WO | disclosed |
| US-20080099945-A1 | Porous substances and methods for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-01 | — | — | US | disclosed |
| US-7247653-B2 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-07-24 | — | — | US | disclosed |
| US-20050272701-A1 | Pharmaceutical composition | ASAKAWA NAOKI | 2005-12-08 | — | — | US | disclosed |
| US-20050232954-A1 | Porous substances and methods for producing the same | YOSHINARI TOMOHIRO | 2005-10-20 | — | — | US | disclosed |
| US-6951885-B2 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-10-04 | — | — | US | disclosed |
| CN-1487936-A | Medicinal compositions having improved absorbability | ����ҩƷ��ҵ��ʽ���� | 2004-04-07 | — | — | CN | disclosed |
| US-20040052854-A1 | Porous substances and methods for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| US-20040053972-A1 | Medicinal compositions having improved absorbability | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| CN-1131213-C | Carbostyril derivatives as antithrombotic agents | NISHI MEDICAL RES INST CO LTD (JP) | 2003-12-17 | — | — | CN | disclosed |
| US-20030216475-A1 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1354581-A1 | POROUS SUBSTANCE AND PROCESS FOR PRODUCING THE SAME | Takeda Chemical Industries, Ltd. (JP) | 2003-10-22 | — | — | EP | disclosed |
| EP-1350793-A1 | MEDICINAL COMPOSITIONS HAVING IMPROVED ABSORBABILITY | Takeda Chemical Industries, Ltd. (JP) | 2003-10-08 | — | — | EP | disclosed |
| EP-1310248-A1 | PHARMACEUTICAL COMPOSITION | Takeda Chemical Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| CN-1172478-A | Quinolone derivative antithrombotic agent | OTSUKA PHARMA CO LTD (JP) | 1998-02-04 | — | — | CN | disclosed |
| US-5536623-A | 6-O-/N-CHLOROACETYLCARBAMOYL/FUMAGILLOL | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-07-16 | — | — | US | disclosed |
| EP-0555693-A1 | Method of producing highly watersoluble cyclodextrin complex | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-08-18 | — | — | EP | disclosed |